iFund

iFund

iFund is a Tokyo-based venture capital firm focused on early-stage investments in Japan. The firm targets seed-stage companies, providing initial capital to founders building across technology-driven sectors. The Japanese seed ecosystem has grown steadily over the past decade, though it still trails markets like the United States and China in total early-stage dollar volume. iFund participates primarily in seed rounds, writing first checks into nascent companies. Its portfolio construction reflects the broader composition of Japan's startup landscape, where enterprise software, consumer internet, and deep tech represent the most active categories. Without a publicly disclosed track record of named portfolio companies, the firm's exact sector concentrations remain unconfirmed, but domestic seed investors in Tokyo typically allocate across SaaS, fintech, and healthcare IT, mirroring the deal flow emerging from local university labs and corporate spinouts. The firm does not publicly disclose fund sizes, specific co-investors, or limited partners. The team size and leadership structure at iFund are not disclosed through public filings or the firm's web presence. Many Japanese micro-VCs operate with fewer than ten professionals and raise capital predominantly from domestic high-net-worth individuals and corporate venturing arms. No adjacent vehicles, philanthropic structures, or international offices have been identified for iFund. No fund closings or major operational events from the last 24 months have been reported. iFund's structural posture is that of a lean, early-stage specialist operating in a market where seed funding is still maturing as an institutional asset class. Unlike larger Japanese venture firms that manage multiple funds across stages and geographies, iFund's apparent focus on seed alone places it in a small cohort of dedicated pre-Series A investors. Its independence from a corporate parent or financial conglomerate would distinguish it from the majority of Japanese venture dollars, which flow through captive CVC arms, though the firm's ownership and GP structure remain unconfirmed.